The Report “Europe Advanced Wound Care Market By Type (Dressings, Active Wound Care, Therapy Devices), By Application (Surgical Wounds, Ulcer), By End-User (In-Patient Facility, and Out-Patient Facility), and By Countries - Analysis & Forecast to 2021” is estimated to reach $2,893.3 million by 2021, growing at a CAGR of 6.7% from 2016 to 2021.
Browse through the TOC of the Europe Advanced Wound Care Market for an analysis of industry trends and segments, with the help of various tables and figures.
Early buyers will receive 10% customization on this report
Globally, the Europe advanced wound care market is the second-largest, after the North American market. The European market is expected to witness substantial growth during the forecast period mainly due to rising incidences of diabetes. Favorable government initiatives and contribution of various independent organizations operational in the wound care market are also expected to drive the market in Europe. The growth will be seen in the active wound care segment.
According to the World Health Organization, there are 60 million diabetics in the European region. The prevalence of diabetes has also increased among all ages. As the wound healing process is slower in diabetics, advanced wound care products are required for the treatment of conditions, such as diabetic foot ulcer. Diabetic foot ulcer is a major complication in a number of people suffering from diabetes. Wound care products, such as artificial skin and skin substitutes, alginates, foam dressings, and negative pressure therapy devices are widely used for the treatment of non-healing diabetic foot ulcers.
Technological advancements in wound care products are expected to drive the growth of the European wound care market. The development of various new products is a major factor driving the growth of this market. Currently, companies are investing heavily in R&D to develop new and advanced products to cater to the needs of patients. For instance, in May 2013, 3M Healthcare (U.S.) launched the 3M PICC/CVC Securement device and Tegaderm I.V. Advanced Securement Dressing (a sutureless securement system). Tegaderm I.V. Advanced Securement Dressing provides advanced adhesion while ensuring patient comfort as compared to traditional securement devices.
The Europe advanced wound care market has been analyzed and segmented on the basis of country into Germany, U.K., Spain, Italy, and France. In 2015, Germany accounted for the largest share of the Europe advanced wound care market. Major players in this market include Smith & Nephew Plc (U.K.), Mölnlycke Health Care (Sweden), ConvaTec, Inc. (U.S.), Laboratoires URGO (France), Coloplast Group (Denmark), Medline Industries, Inc. (U.S.), Organogenesis, Inc. (U.S.), Shire (Ireland), MiMedx Group, Inc. (U.S.), and Integra Life Sciences Corporation (U.S.).
This report also includes market metrics, such as drivers, restraints, and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of key players active in this market.
About MicroMarket Monitor:
MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.
Contact:
Mr. Priyank Tiwari
UNIT no 802, Tower No. 7, SEZ
Magarpatta City, Hadapsar
Pune, Maharashtra 411013, India
Tel: +1-888-502-0539
Email: sales@micromarketmonitor.com
